New epilepsy drug shows promise for Long-Term seizure control
NCT ID NCT07563634
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This study looked at the long-term safety and effectiveness of the drug brivaracetam in 141 Chinese adults with focal epilepsy that was not controlled by other medications. Participants took brivaracetam tablets twice daily for up to a year or more, and could also continue other epilepsy drugs. The main goal was to check for side effects, while also tracking how well the drug controlled seizures over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY, FOCAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.